Hybrid AF™ Therapy with the EPi-Sense System is the first and ONLY FDA-approved device for minimally invasive ablation therapy to treat long-standing persistent Afib—the most prevalent and undertreated Afib patient population.
Discover the EPi-Sense ST™ device: <a href="https://okt.to/Wpznxd" target="_blank">https://okt.to/Wpznxd</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>
